In the last trading session, 5.65 million Intensity Therapeutics Inc (NASDAQ:INTS) shares changed hands as the company’s beta touched 3.98. With the company’s per share price at $0.32 changed hands at $0.01 or 4.58% during last session, the market valuation stood at $8.34M. INTS’s last price was a discount, traded about -1493.75% off its 52-week high of $5.10. The share price had its 52-week low at $0.28, which suggests the last value was 12.5% up since then. When we look at Intensity Therapeutics Inc’s average trading volume, we note the 10-day average is 1.93 million shares, with the 3-month average coming to 1.09 million.
Intensity Therapeutics Inc (NASDAQ:INTS) trade information
Instantly INTS was in green as seen at the end of in last trading. With action 15.52%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -93.71%, with the 5-day performance at 15.52% in the green. However, in the 30-day time frame, Intensity Therapeutics Inc (NASDAQ:INTS) is 2.01% up. Looking at the short shares, we see there were 0.66 million shares sold at short interest cover period of 0.3 days.
The consensus price target for the stock as assigned by Wall Street analysts is 5, meaning bulls need an upside of 93.6% from its current market value. According to analyst projections, INTS’s forecast low is 5 with 5 as the target high. To hit the forecast high, the stock’s price needs a -1462.5% plunge from its current level, while the stock would need to soar -1462.5% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -23.29%. The 2025 estimates are for Intensity Therapeutics Inc earnings to increase by 40.46%, but the outlook for the next 5-year period is at 12.46% per year.
INTS Dividends
Intensity Therapeutics Inc is expected to release its next quarterly earnings report on 2025-May-13.
Intensity Therapeutics Inc (NASDAQ:INTS)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 23.59% of Intensity Therapeutics Inc shares while 9.99% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 13.08%. There are 9.99% institutions holding the Intensity Therapeutics Inc stock share, with SAPIENT CAPITAL LLC the top institutional holder. As of 2024-06-30, the company held 7.3712% of the shares, roughly 1.01 million INTS shares worth $4.95 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 1.4948% or 0.2 million shares worth $1.0 million as of 2024-06-30.
